---
title: "BAIJIN LIFE SCI completed the issuance of 65.3594 million subscription shares"
description: "According to an announcement from BAIJIN LIFE SCI, based on the general authorization approved by the company's shareholders on September 30, 2024, 65,359,400 new shares will be issued on April 3, 202"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/234721834.md"
published_at: "2025-04-07T04:16:02.000Z"
---

# BAIJIN LIFE SCI completed the issuance of 65.3594 million subscription shares

> According to an announcement from BAIJIN LIFE SCI, based on the general authorization approved by the company's shareholders on September 30, 2024, 65,359,400 new shares will be issued on April 3, 2025

According to the announcement from BAIJIN LIFE SCI (01466), the company will issue 65,359,400 new shares on April 3, 2025, based on the general authorization approved by the shareholders on September 30, 2024

### Related Stocks

- [01466.HK - BAIJIN LIFE SCI](https://longbridge.com/en/quote/01466.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 腾讯被错杀了？ | 伯恩斯坦认为，腾讯股价下跌，主要受 AI 模型开发进度落后和游戏行业 AI 颠覆担忧的双重打击。目前腾讯以 14-15 倍 2027 年预期市盈率交易，接近 2022-2023 年行业面临游戏审批停滞和疫情封控时的低谷水平。尽管腾讯在聊天机 | [Link](https://longbridge.com/en/news/275903716.md) |
| 高瓴继续重仓中概股，HHLR 四季度增持阿里巴巴、拼多多，减持网易、百度 | 高瓴 HHLR Advisors Ltd.在四季度增持了阿里巴巴、拼多多、iShares 比特币和台积电，同时减持了网易、Bright Schol、富途控股、百度、满帮和 Webull 等。该公司重仓拼多多、阿里巴巴和富途控股。市场有风险， | [Link](https://longbridge.com/en/news/276176972.md) |
| 快验保｜8-K：2025 财年 Q4 营收 75.1 百万美元超过预期 |  | [Link](https://longbridge.com/en/news/276173254.md) |
| 段永平试水 “AI 交易”：卖苹果加仓英伟达，“新入” CoreWeave、Credo 和 Tempus | CoreWeave 专门搭建高性能 GPU 集群，把算力租给 AI 公司和企业客户；如果说 GPU 是心脏，Credo 提供的高速互联芯片和光模块就是血管，跟 AI 服务器迭代高度绑定；Tempus 则致力于将 AI 应用于精准医疗，尤其是 | [Link](https://longbridge.com/en/news/276189117.md) |
| JELD-WEN 控股｜8-K：2025 财年 Q4 营收 8.02 亿美元超过预期 |  | [Link](https://longbridge.com/en/news/276172078.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.